Navigation Links
National Brain Tumor Society Responds to Results of Avastin Clinical Trials
Date:6/3/2013

Boston, MA (PRWEB) June 03, 2013

National Brain Tumor Society, the largest nonprofit in the United States dedicated to the brain tumor community, issues the following statement regarding clinical trial results involving the cancer drug Avastin reported at the American Society of Clinical Oncology’s 2013 Annual Meeting:

"Beginning in May of 2009, drug maker Genentech received accelerated approval from the U.S. Food and Drug Administration (FDA) to market Avastin (bevacizumab) for the treatment of recurrent glioblastoma multiforme (GBM). National Brain Tumor Society has since followed the progress of Genentech’s required post-market study of Avastin called AVAglio, and has also sought input from the brain tumor community about the role Avastin has played as one of only four approved brain cancer drugs.

National Brain Tumor Society is deeply disappointed in the recently announced results of the AVAglio clinical trial. This trial revealed that Avastin (in combination with standard of care treatments) did not significantly prolong the lives of newly diagnosed GBM patients.

We are equally concerned with additional findings from a large, National Cancer Institute (NCI)-supported clinical trial conducted by the Radiation Therapy Oncology Group (RTOG). Similar to the AVAglio trial, the RTOG study did not show statistically significant increases in overall survival for newly diagnosed GBM patients taking Avastin in combination with standard of care treatments. Data from the AVAglio and RTOG studies collectively have provided mixed results on issues such as progression-free survival (i.e. a measure of tumor growth in response to a therapy) and quality of life, which will require careful and further analysis to better understand their full meaning in terms of patient care.

Avastin is an important part of the current limited treatment landscape for many brain cancer patients. National Brain Tumor Society
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. UV Flu Technologies Expands Its International Footprint
2. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
3. International Attendance for Networking and Education at Informex Beyond Manufacturing
4. Sundberg Kicks Off National Expansion With Openings of New Headquarters, Logistically Centric Mega Warehouses
5. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
6. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
7. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
8. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
9. PAREXEL International to Present at J.P. Morgan Healthcare Conference
10. DFH Pharma to Collaborate With National Cancer Institute to Develop Second-Generation HIV Maturation Inhibitor Drugs
11. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Md. and SUMMERLAND, British Columbia ... (NYSE: XON ), a leader in ... agreement to acquire  Okanagan Specialty Fruits (OSF), the ... apple , the world,s first non-browning apple. Through the ... yielding fruit that is more appetizing and convenient for ...
(Date:2/27/2015)... Mass. , Feb. 27, 2015 ... of the NCATS rare-diseases portfolio " in ... a new financing technique to reduce the risk ... diseases and potentially unlock new levels of funding ... The product of a unique collaboration between scientists ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine ... and immunotherapy company, today announced that the U.S. ... for Fast Track designation and Phase I clinical ... conjunction with the mutual co-development agreement signed with ... Fast Track designation for the DPX-Survivac. , “We ...
(Date:2/27/2015)... 2015 Bionomics Limited (ASX:BNO, ADR:BMICY) is to ... BNC105 in patients with metastatic renal cancer at the ... . The data will be presented by Dr. ... Comprehensive Cancer Center in California ... data identifies Ferritin and IL-8 as two baseline biomarkers ...
Breaking Biology Technology:Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5
... University of Wisconsin-Madison Lidar (Light Detection and Ranging) group was ... Land Elevation Satellite) laser device. Lidars Arctic HSRL ... because it operates on the same wavelength as the ICESat. ... climate and changing polar ice sheets in the Arctic. ...
... business is turning around a sick company before all of ... into bankruptcy. Realizing the painful reality of how bad things ... senior executives to deal with truthfully. They grasp at straws ... close that big outstanding proposal, and things will be back ...
... at a double-digit pace in 2003, but there are indications ... year, according to global HR outsourcing and consulting firm Hewitt ... percent average increase for employers, which is lower than 2003's ... absorb the majority of next year's increase, but many are ...
Cached Biology Technology:UW-Madison Laser Device to Study Polar Ice Caps 2Turning Around a Sick Company 2Health Care Costs Continue Double-Digit Pace, But May Start Moderating in 2004 2Health Care Costs Continue Double-Digit Pace, But May Start Moderating in 2004 3
(Date:2/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces it ... Conference on January 29 th at 10:30 a.m. ... of NXT-ID will present and host a live Q&A ... and its full suite of biometric technologies. Investors can ...
(Date:1/22/2015)... S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform its ... of Washington,s Department of Licensing, in the United ... system for driver,s licenses and identification cards to its subsidiary, ... will start in January 2015, with enrollment and card production ...
(Date:1/22/2015)... N.C. , Jan. 16, 2015  A man-made form ... memory and other mental capabilities in adults with mild ... pilot study led by researchers at Wake Forest Baptist ... adults diagnosed with amnesic mild cognitive impairment (MCI) or ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... the extraction of water for irrigation and overfishing all threaten ... sensitive to changes in its environment and, according to the ... the year 2040 and will have completely disappeared from Iberian ... Global warming is threatening the existence of many fish species, ...
... -- What if you could shut down several emergency ... hacking a pacemaker and reprogramming it to cause a ... an espionage film, they are also some of the ... working to prevent. Eugene Vasserman, assistant professor; John ...
... The Scripps Research Institute have designed a compound that shows ... closely linked to fragile X syndrome, a genetic condition that ... only known single-gene cause of autism. The study, published ... Biology September 4, 2012, focuses on tremor ataxia syndrome, ...
Cached Biology News:Trout will become extinct in the Iberian Peninsula in less than 100 years 2Trout will become extinct in the Iberian Peninsula in less than 100 years 3Internal relations 2Internal relations 3Internal relations 4Scripps Florida scientists design molecule that reverses some fragile X syndrome defects 2
... slides were designed to study protein expression patterns ... Tissue slices from three different species are ... be treated as a single histological slide for ... hybridization. This format allows a rapid analysis ...
...
AVOID FREEZE/THAW CYCLES. Recognizes the ~5 kDa thymosin beta4 protein....
... The Mini-Sub cell GT cell and PowerPac basic ... electrophoresis of nucleic acids in agarose gels. The ... lid with cables and electrodes, a 7 x ... two casting gates, and two 1.5 mm fixed-height ...
Biology Products: